The actress and fiancée of Buffalo Bills quarterback Josh Allen has a sizzling look to promote her new big business venture.
7h
Pharmaceutical Technology on MSNAbcuro secures $200m as it eyes approval for rare muscle disease drugThe funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...
This article discusses the Anti-Kickback Statute and the False Claims Act. "When coupled with the False Claims Act (FCA), the AKS turns into a potent civil enforcement tool that carries many of the ...
Morgan Stanley (NYSE:MS) initiated coverage on Novartis (SIX:NOVN:SW) (NYSE: NVS) with an Underweight rating and set a price ...
Wanda Sykes' provocative Super Bowl ad tackles breast cancer awareness. Discover how early detection saved her life and could save millions more.
Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, sales continue to soar for Lilly and Novo Nordisk’s GLP-1s and Regeneron ...
The pharma giant said it has agreed to acquire the U.S. privately held, clinical-stage biopharmaceutical company to boost its ...
Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.
Financial Times highlights include BP's reduced bonus payout, Entain's CEO stepping down, Novartis' acquisition of Anthos Therapeutics, and EU's planned retaliation against US tariffs on steel and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results